维他费林A通过调节由 ангиотензин II 激活的通路来减轻由 ангиотензин II 诱导的肌肉白血病
Sham S Kakar1,2, Vasa Vemuri1, Mariusz Z Ratajczak2,3
1Department of Physiology, University of Louisville, Louisville, KY 40202, USA.
Cells
|February 25, 2025
概括
维他费林A (WFA) 通过向炎症和缩途径,直接对抗缓解症中的肌肉消耗. 这项研究表明WFA.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 卡切西亚是一种严重的肌肉消耗综合征,通常与癌症有关.
- 维他费林A (WFA) 之前已经显示出缓解癌症诱导的缓解的潜力.
- 没有完全理解WFA对肌肉缩的直接影响.
研究的目的:
- 调查Withaferin A (WFA) 的直接抗凝固作用.
- 为了确定WFA的保护作用是否独立于其抗瘤特性.
- 阐明WFA对骨肌肉的作用背后的分子机制.
主要方法:
- 通过使用连续的血管素II (Ang II) 输液,建立了小鼠缓冲症模型.
- 评估了肌肉质量,握力和炎症和缩的分子标志物.
- 分析了包括无素-蛋白酶体系统 (UPS) 和自在内的关键途径.
主要成果:
- Ang II输液诱导显著的肌肉缩,减少强度,并改变了分子标记.
- 通过WFA治疗,可以扭转这些影响,恢复肌肉质量和功能.
- WFA使炎症性细胞因子,UPS和与自相关的基因的表达正常化.
结论:
- 维他费林A (WFA) 显示对骨肌肉有直接的抗效应.
- WFA针对关键的炎症和缩途径,包括NLRP3炎症体,UPS和自.
- WFA显示出作为治疗药物的潜力,用于控制卡切西亚肌肉消耗.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
Antihypertensive Drugs: Direct Renin Inhibitors
469
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
469
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
455
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
455
Antihypertensive Drugs: Angiotensin II Receptor Blockers
571
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
571
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


